4/17
09:48 pm
abt
Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty [Yahoo! Finance]
Neutral
Report
Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty [Yahoo! Finance]
4/17
09:40 pm
abt
Stocks tumble Wednesday as White House curbs chip exports, Powell warns on trade war [Yahoo! Finance]
Neutral
Report
Stocks tumble Wednesday as White House curbs chip exports, Powell warns on trade war [Yahoo! Finance]
4/17
07:49 pm
abt
Abbott Labs is a textbook recession play, says Jim Cramer [CNBC]
Neutral
Report
Abbott Labs is a textbook recession play, says Jim Cramer [CNBC]
4/17
07:38 pm
abt
Abbott Labs Bracing for Tariffs as Profits Rise [Yahoo! Finance]
Low
Report
Abbott Labs Bracing for Tariffs as Profits Rise [Yahoo! Finance]
4/17
05:21 pm
abt
Nvidia, ASML, Abbott Labs: Stocks to watch today [Yahoo! Finance]
Low
Report
Nvidia, ASML, Abbott Labs: Stocks to watch today [Yahoo! Finance]
4/17
01:31 pm
abt
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $133.00.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $133.00.
4/17
01:31 pm
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Raymond James from $132.00 to $142.00. They now have an "outperform" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Raymond James from $132.00 to $142.00. They now have an "outperform" rating on the stock.
4/17
12:36 pm
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Royal Bank of Canada from $140.00 to $145.00. They now have an "outperform" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Royal Bank of Canada from $140.00 to $145.00. They now have an "outperform" rating on the stock.
4/17
11:56 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Morgan Stanley from $117.00 to $127.00. They now have an "equal weight" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Morgan Stanley from $117.00 to $127.00. They now have an "equal weight" rating on the stock.
4/17
11:56 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $136.00 to $147.00. They now have an "overweight" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $136.00 to $147.00. They now have an "overweight" rating on the stock.
4/17
11:06 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Barclays PLC from $158.00 to $159.00. They now have an "overweight" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Barclays PLC from $158.00 to $159.00. They now have an "overweight" rating on the stock.
4/17
09:15 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $135.00 to $145.00. They now have a "buy" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $135.00 to $145.00. They now have a "buy" rating on the stock.
4/17
08:48 am
abt
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Jefferies Financial Group Inc. from $135.00 to $137.00. They now have a "hold" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Jefferies Financial Group Inc. from $135.00 to $137.00. They now have a "hold" rating on the stock.
4/17
08:27 am
abt
Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025 [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025 [Yahoo! Finance]
4/17
02:25 am
abt
“Rotation Carnage”: Jim Cramer Blames a Bad Rotation for Abbott Laboratories (ABT)'s Fall from Grace [Yahoo! Finance]
Low
Report
“Rotation Carnage”: Jim Cramer Blames a Bad Rotation for Abbott Laboratories (ABT)'s Fall from Grace [Yahoo! Finance]
4/16
08:10 pm
abt
Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
4/16
08:10 pm
abt
Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market [Yahoo! Finance]
Low
Report
Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market [Yahoo! Finance]
4/16
04:24 pm
abt
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers [Yahoo! Finance]
Low
Report
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers [Yahoo! Finance]
4/16
04:19 pm
abt
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers [Yahoo! Finance Canada]
Low
Report
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers [Yahoo! Finance Canada]
4/16
02:31 pm
abt
Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities [Yahoo! Finance]
Low
Report
Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities [Yahoo! Finance]
4/16
02:11 pm
abt
Abbott Laboratories (NYSE:ABT) Reports Q1 Sales And Income Growth With Earnings At US$0.76 [Yahoo! Finance]
Low
Report
Abbott Laboratories (NYSE:ABT) Reports Q1 Sales And Income Growth With Earnings At US$0.76 [Yahoo! Finance]
4/16
12:20 pm
abt
Nvidia and chip stocks drag down the Nasdaq as markets slip on trade war woes [Yahoo! Finance]
Low
Report
Nvidia and chip stocks drag down the Nasdaq as markets slip on trade war woes [Yahoo! Finance]
4/16
11:02 am
abt
Generic Drugs Market Size Worth $728.64 Bn by 2034 | Driven by Affordability, Patent Expirations, and Government Support [Yahoo! Finance]
Low
Report
Generic Drugs Market Size Worth $728.64 Bn by 2034 | Driven by Affordability, Patent Expirations, and Government Support [Yahoo! Finance]
4/16
09:44 am
abt
Stocks open lower as White House restricts semiconductor exports, earnings season rolls on [USA TODAY]
Low
Report
Stocks open lower as White House restricts semiconductor exports, earnings season rolls on [USA TODAY]
4/16
09:17 am
abt
Abbott Laboratories Stock Slips as First-Quarter Sales Miss Expectations [Yahoo! Finance]
Low
Report
Abbott Laboratories Stock Slips as First-Quarter Sales Miss Expectations [Yahoo! Finance]